All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Unveiling HDAC8 antagonists for breast cancer therapy via molecular modeling

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216305%3A26220%2F25%3APU152639" target="_blank" >RIV/00216305:26220/25:PU152639 - isvavai.cz</a>

  • Result on the web

    <a href="https://ieeexplore.ieee.org/document/10822550" target="_blank" >https://ieeexplore.ieee.org/document/10822550</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1109/BIBM62325.2024.10822550" target="_blank" >10.1109/BIBM62325.2024.10822550</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Unveiling HDAC8 antagonists for breast cancer therapy via molecular modeling

  • Original language description

    Histone deacetylases (HDACs) are epigenetic enzymes that are crucial in tumor formation and are potential therapeutic targets for breast cancer treatment. HDACs catalyze the deacetylation of histone and nonhistone proteins. HDAC8 belongs to class I and is reported to be overexpressed in breast cancer initiation and its progression. HDAC8 interacts with the estrogen receptor (ER) and leads to transcriptional inactivation, thus formation of breast cancer. The present in-silico study involves molecular modeling approaches such as virtual screening, molecular docking, molecular dynamic simulations, free binding energy, and essential dynamic analysis to find HDAC8 antagonists for breast cancer treatment. The study unveils top three virtual hits as potential lead compounds for breast cancer therapy.

  • Czech name

  • Czech description

Classification

  • Type

    D - Article in proceedings

  • CEP classification

  • OECD FORD branch

    10620 - Other biological topics

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Article name in the collection

    2024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)

  • ISBN

    979-8-3503-8622-6

  • ISSN

    2156-1133

  • e-ISSN

  • Number of pages

    4

  • Pages from-to

    852-855

  • Publisher name

    IEEE

  • Place of publication

    Lisbon, Portugal

  • Event location

    Lisbon

  • Event date

    Dec 3, 2024

  • Type of event by nationality

    WRD - Celosvětová akce

  • UT code for WoS article